Page last updated: 2024-10-16

quinacrine and Central Nervous System Diseases

quinacrine has been researched along with Central Nervous System Diseases in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROCHLIN, DB1
SMART, CR1
WAGNER, DE1
SILVA, AR1
Huriez, C1
Desmons, F1
Gautier, G1

Other Studies

2 other studies available for quinacrine and Central Nervous System Diseases

ArticleYear
THE CONTROL OF RECURRENT MALIGNANT EFFUSIONS USING QUINACRINE HYDROCHLORIDE.
    Surgery, gynecology & obstetrics, 1964, Volume: 118

    Topics: Ascites; Biomedical Research; Breast Neoplasms; Central Nervous System Diseases; Colonic Neoplasms;

1964
[Complications with synthetic antimalarials].
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1969, Volume: 14, Issue:8

    Topics: Antimalarials; Asthenia; Central Nervous System Diseases; Chloroquine; Drug Eruptions; Eczema; Eye D

1969